The multicentre, randomised trial was conducted in China, but Sichuan-Kelun and Merck & Co will commercialise sac-TMT in ...

Pfizer is suing Novo Nordisk following the Danish pharma's last-minute bid to acquire Metsera, which Pfizer called “reckless” ...

D Molecular Therapeutics (4DMT) has announced an exclusive licence agreement with Otsuka Pharmaceutical to develop and market 4D-150.

IntoCell has announced a MoU with US-based contract development and manufacturing organisatioXcellon Biologics.

Bayer and BI have reported broadly similar efficacy outcomes for sevabertinib and Hernexeos in HER2-mutant NSCLC.

The DREAMM-7 trial showed tolerability and safety profiles consistent with those observed for individual therapies. Credit: ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Swiss-based Debiopharm has formed a research partnership with South Korea-based AI drug discovery company NetTargets.

Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...

Health Canada has issued a Notice of Compliance (NOC) for AstraZeneca’s HER2-directed antibody drug conjugate (ADC) Enhertu.